Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 429-435

  Ye, Chuanzhong ^a   Shrubsole, Martha J ^a   Cai, Qiuyin ^a   Ness, Reid ^a,c   Grady, William M ^d   Smalley, Walter ^a,c   Cai, Hui ^a   Washington, Kay ^b   Zheng, Wei ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Veterans Affairs Tennessee Valley Health Care System   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

CDKN2A p16; Colorectal adenomas; hMLH1; Methylation; MGMT

Indexed keywords

CARRIER PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADENOMA; AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC EPIGENESIS; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADENOMA; AGED; CARRIER PROTEINS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, P16; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS);

EID: 33748528622     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.429     Document Type: Article

References (29)

1. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR and Wu TT: Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162: 815-822, 2003. (Pubitemid 36237490)
2. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916-932, 1999.
3. Momparler RL and Bovenzi V: DNA methylation and cancer. J Cell Physiol 183: 145-154, 2000. (Pubitemid 30185933)
4. Lee S, Hwang KS, Lee HJ, Kim JS and Kang GH: Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84: 884-893, 2004. (Pubitemid 38833248)
5. Rashid A, Shen L, Morris JS, Issa JP and Hamilton SR: CpG island methylation in colorectal adenomas. Am J Pathol 159: 1129-1135, 2001. (Pubitemid 32847204)
6. Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58: 5489-5494, 1998. (Pubitemid 28551135)
7. Kondo Y and Issa JP: Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 23: 29-39, 2004. (Pubitemid 38221595)
8. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999. (Pubitemid 29354851)
9. Esteller M, Hamilton SR, Burger PC, Baylin SB and Herman JG: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797, 1999. (Pubitemid 29086728)
10. Whitehall VL, Walsh MD, Young J, Leggett BA and Jass JR: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61: 827-830, 2001. (Pubitemid 32174386)
11. Esteller M and Herman JG: Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 23: 1-8, 2004. (Pubitemid 38142234)
12. Herfarth KK, Brent TP, Danam RP, Remack JS, Kodner IJ, Wells SA Jr, et al: A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinog 24: 90-98, 1999. (Pubitemid 29115911)
13. Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, et al: O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13: 967-975, 2004. (Pubitemid 38756707)
14. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, et al : Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61: 6991-6995, 2001. (Pubitemid 32946483)
15. Waki T, Tamura G, Sato M and Motoyama T: Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22: 4128-4133, 2003. (Pubitemid 36819653)
16. Jubb AM, Bell SM and Quirke P: Methylation and colorectal cancer. J Pathol 195: 111-134, 2001.
17. Guan RJ, Fu Y, Holt PR and Pardee AB: Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology 116: 1063-1071, 1999. (Pubitemid 29203016)
18. Giovannucci E and Ogino S: DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 97: 1317-1319, 2005. (Pubitemid 41487792)
19. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, et al : MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97: 1330-1338, 2005. (Pubitemid 41487800)
20. Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, et al: Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91: 2294-2301, 2001. (Pubitemid 32552815)
21. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S and Motoyama T: Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 161: 399-403, 2002. (Pubitemid 36142148)
22. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
23. Toyota M, Ohe-Toyota M, Ahuja N and Issa JP: Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 97: 710-715, 2000. (Pubitemid 30070374)
24. Bai AH, Tong JH, To KF, Chan MW, Man EP, Lo KW, et al: Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 112: 846-853, 2004. (Pubitemid 39435270)
25. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, et al : Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 11: 1203-1209, 2005. (Pubitemid 40175772)
26. Kim SH, Bae SI, Lee HS and Kim WH: Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients. Mol Carcinog 37: 32-38, 2003. (Pubitemid 36535126)
27. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, et al : Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64: 4442-4452, 2004. (Pubitemid 38856915)
28. Xiong Z, Wu AH, Bender CM, Tsao JL, Blake C, Shibata D, et al: Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas. Cancer Epidemiol Biomarkers Prev 10: 799-803, 2001. (Pubitemid 32695160)
29. Luo L, Chen WD and Pretlow TP: CpG island methylation in aberrant crypt foci and cancers from the same patients. Int J Cancer 115: 747-751, 2005. (Pubitemid 40776698)